Ernst Wellnhofer
Overview
Explore the profile of Ernst Wellnhofer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
707
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gbaoui L, Hoeschen C, Kaniusas E, Khatib S, Gretschel S, Wellnhofer E
Front Cardiovasc Med
. 2023 Dec;
10:1280899.
PMID: 38045918
Background: Central blood pressure () is a better indicator of cardiovascular morbidity and mortality than peripheral BP (). However, direct measurement requires invasive techniques and indirect measurement is based on...
2.
Wellnhofer E
Front Cardiovasc Med
. 2022 Aug;
9:890809.
PMID: 35935648
Recent progress in digital health data recording, advances in computing power, and methodological approaches that extract information from data as artificial intelligence are expected to have a disruptive impact on...
3.
Lapinskas T, Kelle S, Grune J, Foryst-Ludwig A, Meyborg H, Jeuthe S, et al.
J Am Heart Assoc
. 2020 Feb;
9(3):e013702.
PMID: 32000566
Background Animal studies demonstrated that serelaxin lessens fibrosis in heart failure. This study assessed its effect on myocardial deformation using cardiac magnetic resonance and elucidated its relationship to gene regulation...
4.
Caglayan E, Trappiel M, Behringer A, Berghausen E, Odenthal M, Wellnhofer E, et al.
Respir Res
. 2019 Mar;
20(1):42.
PMID: 30813929
Background: Obesity is associated with cardiovascular complications, including pulmonary hypertension (PH). Reports suggest that peroxisome proliferator-activated receptor-γ (PPARγ) has direct action in preventing vascular remodelling in PH. Here we dissected...
5.
Gehle P, Robinson P, Heinzel F, Edelmann F, Yigitbasi M, Berger F, et al.
Int J Cardiol Heart Vasc
. 2017 Jun;
12:15-20.
PMID: 28616536
Aims: Subclinical diastolic dysfuntion in patients with preclinical heart failure with preserved ejection fraction (HFpEF) has been demonstrated in patients with Marfan syndrome (MFS). We investigated the relationship between diastolic...
6.
Kruger J, Wellnhofer E, Meyborg H, Stawowy P, Ostman A, Kintscher U, et al.
FEBS Open Bio
. 2016 Apr;
6(3):179-89.
PMID: 27047746
Insulin resistance plays a crucial role in the development of type 2 diabetes. Insulin receptor signalling is antagonized and tightly controlled by protein tyrosine phosphatases (PTPs). However, the precise role...
7.
Doltra A, Hartmann A, Stawowy P, Goubergrits L, Kuehne T, Wellnhofer E, et al.
PLoS One
. 2016 Mar;
11(3):e0150662.
PMID: 27003912
Aim: To study the effects of RD on renal artery wall function non-invasively using magnetic resonance. Methods And Results: 32 patients undergoing RD were included. A 3.0 Tesla magnetic resonance...
8.
Kaufmann J, Wellnhofer E, Stockmann H, Graf K, Fleck E, Schroeder T, et al.
Resuscitation
. 2016 Mar;
102:63-9.
PMID: 26924513
Background: Target temperature management (TTM) after cardiac arrest (CA) improves outcome in patients with acute coronary syndrome (ACS). Previous data point to an interaction between hypothermia and drug metabolism, potentially...
9.
Behringer A, Trappiel M, Berghausen E, Freyhaus H, Wellnhofer E, Odenthal M, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2016 Jan;
389(4):369-79.
PMID: 26742933
Pulmonary arterial hypertension (PAH) is a fatal disease with limited therapeutic options. Pathophysiological changes comprise obliterative vascular remodelling of small pulmonary arteries, elevated mean pulmonary arterial systolic pressure (PASP) due...
10.
Deaconu A, Iancovici S, Wellnhofer E, Berger A, Gebker R, Pieske B, et al.
Int J Cardiol
. 2015 Aug;
201:438-40.
PMID: 26313862
No abstract available.